Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer
Abstract Background Despite improvement of tumour response rates in patients with progressive and metastatic cancer, immune checkpoint inhibitors (ICM) induce toxicities in cancer patients. Viscum album L. (VA, mistletoe) extracts are applied as add-on cancer therapy especially in German speaking co...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2017-12-01
|
| シリーズ: | BMC Complementary and Alternative Medicine |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s12906-017-2045-0 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|